Mountain View, CA, June 6, 2003
Nevada State Health
Division, Central Cancer Registry (CCR) announced the selection of
Précis-Central, an enterprise-wide data management and reporting
tool from IMPAC Medical Systems, Inc. (NASDAQ:IMPC), to help
registrars and physicians significantly improve efficiency
throughout the entire central registry in Nevada.
According to Karen Power, MPH, program manager at CCR, the
facility is excited about using the IMPAC system. CCR chose the
IMPAC system after spending a significant time defining and
documenting process and system requirements and evaluating
software. “During the selection process, CCR defined hundreds of
business functions, and vendors were evaluated on a variety of
dimensions including their ability to meet those functions,”
explained Power. “IMPAC scored the highest of the vendors with a
95% ranking on overall functionality, and a compiled score on the
critical components of more than twice their competition.”
With Précis-Central, CCR will be able to efficiently collect,
manage, and analyze patient demographic, tumor, and treatment
outcome data for public health planning, epidemiological research,
or enterprise-wide forecasting. “Précis is a great system for CCR
because it combines the speed of automation with the expertise of
the registrar to provide a faster, more efficient registry
management solution,” said Donna Getreuer, RN, MSN, CTR, and
IMPAC’s senior product manager for cancer registry systems. “With
Précis, CCR will be able to gather accurate and complete data on
the occurrence of cancer in Nevada to support measures for the
improvement of public health,” she added.
CCR is one of 53 state and territorial central cancer registries
in the United States that works closely with the Centers for
Disease Control (CDC) and the National Program of Cancer
Registries (NPCR) to collect data about the occurrence of cancer,
as well as the outcome of treatment and clinical management.
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc. is a leading provider of specialized
IT solutions that streamline both clinical and business operations
to help improve the process of delivering quality patient care.
With open integration to multiple healthcare data and imaging
systems, IMPAC offers a comprehensive IT solution that includes
specialized electronic charting, full-featured practice
management, clinical laboratory management, and outcomes
reporting. Supporting over 1500 installations worldwide, IMPAC
delivers practical solutions that deliver better overall
communication, process efficiency and quality patient care. For
more information about IMPAC Medical Systems’ products and
services, please call 650-623-8800 or visit www.impac.com.
The statements contained in this press
release that are not purely historical are forward looking
statements within the meaning of Section 21E of the Securities and
Exchange Act of 1934, including statements regarding the Company's
expectations, beliefs, hopes, intentions or strategies regarding
the future. Forward looking statements include statements
regarding the Company's business strategy, timing of, and plans
for, the introduction of new products and enhancements, future
sales, market growth and direction, competition, market share,
revenue growth, operating margins and profitability. All forward
looking statements included in this document are based upon
information available to the Company as of the date hereof, and
the Company assumes no obligation to update any such forward
looking statement. Actual results could differ materially from the
Company's current expectations. Factors that could cause or
contribute to such differences include the Company's ability to
expand outside the radiation oncology market or expand into
international markets, integrate its products successfully with
related products and systems in the medical services industry,
reliance on distributors and manufacturers of oncology equipment
to market its products, and other factors and risks discussed in
the Company's Final Prospectus dated May 12, 2003 and other
reports filed by the Company from time to time with the Securities
and Exchange Commission. |
